ID

16800

Descrizione

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00078468

collegamento

https://clinicaltrials.gov/show/NCT00078468

Keywords

versioni (1)
  1. 08/08/16 08/08/16 -
Caricato su

8 agosto 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Colorectal Neoplasms NCT00078468

Inglese

Eligibility Colorectal Neoplasms NCT00078468

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed metastatic adenocarcinoma of the colon or rectum
Descrizione

Adenocarcinoma of colon metastatic | Adenocarcinoma of rectum metastatic

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0338106
UMLS CUI [1,2]
C1522484
UMLS CUI [2,1]
C0149978
UMLS CUI [2,2]
C1522484
stage iv or recurrent disease
Descrizione

TNM clinical staging | Recurrent disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C0277556
measurable disease
Descrizione

Measurable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
disease progression or recurrence during or after completion of prior first-line chemotherapy with fluorouracil and leucovorin calcium (5-fu/lv)
Descrizione

Disease Progression | Disease recurrence | fluorouracil/leucovorin calcium | Chemotherapy First line treatment Complete

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0679254
UMLS CUI [3]
C0278707
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C1708063
UMLS CUI [4,3]
C0205197
prior irinotecan or oxaliplatin as part of the 5-fu/lv regimen or as subsequent therapy allowed
Descrizione

irinotecan | oxaliplatin | fluorouracil/leucovorin calcium

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0123931
UMLS CUI [2]
C0069717
UMLS CUI [3]
C0278707
only 2 prior regimens for metastatic disease allowed
Descrizione

Prior Therapy Quantity Neoplasm Metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
one additional regimen as adjuvant therapy allowed provided patient remained disease-free for > 6 months after completion of therapy*
Descrizione

Adjuvant therapy Quantity | Disease Free of

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0332296
newer, targeted investigational agents (e.g., cetuximab or bevacizumab) are not
Descrizione

Investigational New Drugs Targeted | cetuximab | bevacizumab

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1521840
UMLS CUI [2]
C0995188
UMLS CUI [3]
C0796392
counted as a chemotherapeutic regimen unless used in combination with a cytotoxic regimen note: *if evidence of failure occurred within < 6 months after completion of adjuvant therapy, patients may have received only 1 additional regimen for metastatic disease
Descrizione

Chemotherapy | Combined Modality Therapy | Cytotoxic agent | Adjuvant therapy Complete failed | Additional Therapy Quantity Neoplasm Metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0009429
UMLS CUI [3]
C0304497
UMLS CUI [4,1]
C0677850
UMLS CUI [4,2]
C0205197
UMLS CUI [4,3]
C0231175
UMLS CUI [5,1]
C1706712
UMLS CUI [5,2]
C1265611
UMLS CUI [5,3]
C0027627
no active brain metastases (requiring treatment or progressing)
Descrizione

Metastatic malignant neoplasm to brain Requirement Therapeutic procedure | Disease Progression

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [2]
C0242656
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of blood transfusion within 14 days
Descrizione

Blood Transfusion

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005841
need of concurrent administration of allopurinol
Descrizione

Allopurinol Patient need for

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0002144
UMLS CUI [1,2]
C0686904
history of radiotherapy or chemotherapy within 4 weeks
Descrizione

Therapeutic radiology procedure | Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0392920
any psychological or sociological condition, addidtive disorder or family problems that might preclude compliance with the protocol
Descrizione

Condition Exclusion Protocol Compliance | Addictive Behavior Exclusion Protocol Compliance | Family problems Exclusion Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2828389
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C0085281
UMLS CUI [2,2]
C2828389
UMLS CUI [2,3]
C0525058
UMLS CUI [3,1]
C0424960
UMLS CUI [3,2]
C2828389
UMLS CUI [3,3]
C0525058
any unstable or severe intercurrent medical condition that in the opinion of th einvestigator might interfere with achievement of study objectives
Descrizione

medical condition Unstable Interferes with Protocol Compliance | medical condition Severe Interferes with Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0443343
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C0525058
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0525058
receipt of an investigational agent within 28 days prior to first day of dosing with ag-2037
Descrizione

Investigational New Drugs | AG2037

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C0935874
pregnant or breast feeding
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
previous treatment with garft inhibitors
Descrizione

Glycinamide Ribonucleotide Formyltransferase Inhibitor

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1512220
history of a malignancy (other than colorectal cancer) excpet those treated with curative intent for skin cancer (other than melanoma) or in situ breast or cervical cancer or those treated with curative intent for any other cancer with no evidence of disease for 5 years
Descrizione

Malignant Neoplasms | Colorectal Carcinoma | curative treatment Skin carcinoma | curative treatment Stage 0 Breast Carcinoma | curative treatment Cervix carcinoma | curative treatment Malignant Neoplasms | Disease Evidence

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0009402
UMLS CUI [3,1]
C1273390
UMLS CUI [3,2]
C0699893
UMLS CUI [4,1]
C1273390
UMLS CUI [4,2]
C0154084
UMLS CUI [5,1]
C1273390
UMLS CUI [5,2]
C0302592
UMLS CUI [6,1]
C1273390
UMLS CUI [6,2]
C0006826
UMLS CUI [7,1]
C0012634
UMLS CUI [7,2]
C3887511
active brain metastases (requiring treatment or progression)
Descrizione

Metastatic malignant neoplasm to brain Requirement Therapeutic procedure | Disease Progression

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [2]
C0242656
Ritorna all'inizio della pagina

Similar models

Eligibility Colorectal Neoplasms NCT00078468

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of colon metastatic | Adenocarcinoma of rectum metastatic
Item
histologically or cytologically confirmed metastatic adenocarcinoma of the colon or rectum
boolean
C0338106 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
C0149978 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
TNM clinical staging | Recurrent disease
Item
stage iv or recurrent disease
boolean
C3258246 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
Measurable Disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
Disease Progression | Disease recurrence | fluorouracil/leucovorin calcium | Chemotherapy First line treatment Complete
Item
disease progression or recurrence during or after completion of prior first-line chemotherapy with fluorouracil and leucovorin calcium (5-fu/lv)
boolean
C0242656 (UMLS CUI [1])
C0679254 (UMLS CUI [2])
C0278707 (UMLS CUI [3])
C0392920 (UMLS CUI [4,1])
C1708063 (UMLS CUI [4,2])
C0205197 (UMLS CUI [4,3])
irinotecan | oxaliplatin | fluorouracil/leucovorin calcium
Item
prior irinotecan or oxaliplatin as part of the 5-fu/lv regimen or as subsequent therapy allowed
boolean
C0123931 (UMLS CUI [1])
C0069717 (UMLS CUI [2])
C0278707 (UMLS CUI [3])
Prior Therapy Quantity Neoplasm Metastasis
Item
only 2 prior regimens for metastatic disease allowed
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Adjuvant therapy Quantity | Disease Free of
Item
one additional regimen as adjuvant therapy allowed provided patient remained disease-free for > 6 months after completion of therapy*
boolean
C0677850 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
Investigational New Drugs Targeted | cetuximab | bevacizumab
Item
newer, targeted investigational agents (e.g., cetuximab or bevacizumab) are not
boolean
C0013230 (UMLS CUI [1,1])
C1521840 (UMLS CUI [1,2])
C0995188 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
Chemotherapy | Combined Modality Therapy | Cytotoxic agent | Adjuvant therapy Complete failed | Additional Therapy Quantity Neoplasm Metastasis
Item
counted as a chemotherapeutic regimen unless used in combination with a cytotoxic regimen note: *if evidence of failure occurred within < 6 months after completion of adjuvant therapy, patients may have received only 1 additional regimen for metastatic disease
boolean
C0392920 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0304497 (UMLS CUI [3])
C0677850 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0231175 (UMLS CUI [4,3])
C1706712 (UMLS CUI [5,1])
C1265611 (UMLS CUI [5,2])
C0027627 (UMLS CUI [5,3])
Metastatic malignant neoplasm to brain Requirement Therapeutic procedure | Disease Progression
Item
no active brain metastases (requiring treatment or progressing)
boolean
C0220650 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Blood Transfusion
Item
history of blood transfusion within 14 days
boolean
C0005841 (UMLS CUI [1])
Allopurinol Patient need for
Item
need of concurrent administration of allopurinol
boolean
C0002144 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
Therapeutic radiology procedure | Chemotherapy
Item
history of radiotherapy or chemotherapy within 4 weeks
boolean
C1522449 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Condition Exclusion Protocol Compliance | Addictive Behavior Exclusion Protocol Compliance | Family problems Exclusion Protocol Compliance
Item
any psychological or sociological condition, addidtive disorder or family problems that might preclude compliance with the protocol
boolean
C0348080 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0085281 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0424960 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0525058 (UMLS CUI [3,3])
medical condition Unstable Interferes with Protocol Compliance | medical condition Severe Interferes with Protocol Compliance
Item
any unstable or severe intercurrent medical condition that in the opinion of th einvestigator might interfere with achievement of study objectives
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0525058 (UMLS CUI [2,4])
Investigational New Drugs | AG2037
Item
receipt of an investigational agent within 28 days prior to first day of dosing with ag-2037
boolean
C0013230 (UMLS CUI [1])
C0935874 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Glycinamide Ribonucleotide Formyltransferase Inhibitor
Item
previous treatment with garft inhibitors
boolean
C1512220 (UMLS CUI [1])
Malignant Neoplasms | Colorectal Carcinoma | curative treatment Skin carcinoma | curative treatment Stage 0 Breast Carcinoma | curative treatment Cervix carcinoma | curative treatment Malignant Neoplasms | Disease Evidence
Item
history of a malignancy (other than colorectal cancer) excpet those treated with curative intent for skin cancer (other than melanoma) or in situ breast or cervical cancer or those treated with curative intent for any other cancer with no evidence of disease for 5 years
boolean
C0006826 (UMLS CUI [1])
C0009402 (UMLS CUI [2])
C1273390 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1273390 (UMLS CUI [4,1])
C0154084 (UMLS CUI [4,2])
C1273390 (UMLS CUI [5,1])
C0302592 (UMLS CUI [5,2])
C1273390 (UMLS CUI [6,1])
C0006826 (UMLS CUI [6,2])
C0012634 (UMLS CUI [7,1])
C3887511 (UMLS CUI [7,2])
Metastatic malignant neoplasm to brain Requirement Therapeutic procedure | Disease Progression
Item
active brain metastases (requiring treatment or progression)
boolean
C0220650 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial